Dr. Janeway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Avenue
Boston, MA 02215- Is this information wrong?
Education & Training
- Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2004
- Harvard Medical SchoolClass of 2000
Certifications & Licensure
- ME State Medical License Current
- RI State Medical License 2022 - 2024
- VT State Medical License 2022 - 2024
- MA State Medical License 2003 - 2024
- CT State Medical License 2022 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- iCAT for Recurrent/Refractory/HR Solid Tumors Start of enrollment: 2012 Aug 01
- The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study Start of enrollment: 2015 Oct 01
- Olaparib With Ceralasertib in Recurrent Osteosarcoma Start of enrollment: 2020 Nov 24
Publications & Presentations
PubMed
- Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors.Andrew Groves, Abigail Ward, Yvonne Y Li, Lorena Lazo de la Vega, Anwesha Nag, Suzanne J Forrest, Hersh V Gupta, Aaron R Thorner, Matthew Meyerson, Junne Kamihara, And...> ;Pediatric Blood & Cancer. 2023 Nov 1
- 9 citationsThe Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.Joseph A Flores-Toro, Subhashini Jagu, Gregory T Armstrong, David F Arons, Gregory J Aune, Stephen J Chanock, Douglas S Hawkins, Allison Heath, Lee J Helman, Katherine...> ;Journal of Clinical Oncology. 2023 Aug 20
- A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors.Raja Shaikh, Brent R Weil, Christopher B Weldon, Nan Chen, Wendy B London, Morgan Krush, Megan Anderson, Mark Gebhardt, Alanna J Church, Steven G DuBois, Yana Pikman, ...> ;Cancer Medicine. 2023 Jun 1
- Join now to see all
Journal Articles
- Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer PopulationKhanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation
- Integrated Genetic and Pharmacologic Interrogation of Rare CancersAndrew L Hong, Katherine A Janeway, Brian D Crompton, Kimberly Stegmaier, Levi A Garraway, Alanna J Church, Stuart L Schreiber, William C Hahn, Nature
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Refining the Genomic Landscape of Pediatric Cancers2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Chemotherapy and radiation therapy in the management of osteosarcomaJaneway KA, Goorin AM, Maki R
http://www.uptodate.com/contents/chemotherapy-and-radiation-therapy-in-the-management-of-osteosarcom
UpToDate, Wolters Kluwer Health - 2012-12-06
Press Mentions
- Genomic ‘Fingerprinting’ Yields Better Treatments for Pediatric Solid CancersJune 24th, 2022
- Study Shows That Genomic Tumor Profiling of Pediatric Tumors Can Enhance Clinical CareJune 23rd, 2022
- A Discussion with Cancer Discovery’s Editors-in-ChiefAugust 5th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Boston Children's HospitalBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: